Suchergebnisse - "Ortiz-Perez, Ana"

PubPharm (12)

1

Imaging Diffusion and Stability of Single-Chain Polymeric Nanoparticles in a Multi-Gel Tumor-on-a-Chip Microfluidic Device

enthalten in: Small methods | 2024

von Deng, L. | Olea, A. | Ortiz-Perez, A. | +5

2

Advanced optical imaging for the rational design of nanomedicines

enthalten in: Advanced drug delivery reviews | 2024

von Ortiz-Perez, A. | Zhang, M. | Fitzpatrick, L. | +2

3

Machine learning-guided high throughput nanoparticle design

enthalten in: chemRxiv.org | 2023

von Ortiz-Perez, A. | van Tilborg, D. | van der Meel, R. | +2

4

Identification of fluorescently-barcoded nanoparticles using machine learning

enthalten in: Nanoscale advances | 2023

von Ortiz-Perez, A. | Izquierdo-Lozano, C. | Meijers, R. | +2

5

High Mobility Group Box 1 Release by Cholangiocytes Governs Biliary Atresia Pathogenesis and Correlates With Increases in Afflicted Infants

enthalten in: Hepatology (Baltimore, Md.) | 2021

von Mohanty, S. | Donnelly, B. | Temple, H. | +11

CommentIn: Hepatology. 2021 Nov;74(5):2920-2921. - PMID 34164831

6

High Mobility Group Box 1 Release by Cholangiocytes Governs Biliary Atresia Pathogenesis and Correlates With Increases in Afflicted Infants

enthalten in: Hepatology | 2021

von Mohanty, S. | Donnelly, B. | Temple, H. | +11

7

Pharmacological inhibition of STAT3 pathway ameliorates acute liver injury in vivo via inactivation of inflammatory macrophages and hepatic stellate cells

enthalten in: FASEB bioAdvances | 2020

von Öztürk Akcora, B. | Vassilios Gabriël, A. | Ortiz-Perez, A. | +1

8

Innate Immunity and Pathogenesis of Biliary Atresia

enthalten in: Frontiers in immunology | 2020

von Ortiz-Perez, A. | Donnelly, B. | Temple, H. | +3

9

Pharmacological inhibition of STAT3 pathway ameliorates acute liver injury in vivo via inactivation of inflammatory macrophages and hepatic stellate cells

enthalten in: FASEB BioAdvances | 2020

von Öztürk Akcora, B. | Vassilios Gabriël, A. | Ortiz‐Perez, A. | +1

10

TG101348, a selective JAK2 antagonist, ameliorates hepatic fibrogenesis in vivo

enthalten in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology | 2019

von Akcora, B. | Dathathri, E. | Ortiz-Perez, A. | +4